The role of pharmacokinetic modelling and computer simulation in drug formulation design

Computers in Biology and Medicine

Volumn 28, Issue 4, 1998, Pages 365-376

  Grabnar, I ^a   Belic A ^a   Mrhar, A ^a   Karba, R ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

Drug formulation design; Modelling and simulation; Nitrendipine; Optimisation of antihypertensive effect; Pharmacokinetics

Indexed keywords

COMPUTER SIMULATION; DRUG PRODUCTS; MATHEMATICAL MODELS; OPTIMIZATION; PHARMACOKINETICS;

ANTIHYPERTENSIVE EFFECT; DRUG FORMULATION DESIGN; NITRENDIPINE;

CONTROLLED DRUG DELIVERY;

ANTIHYPERTENSIVE AGENT; NITRENDIPINE;

COMPARTMENT MODEL; COMPUTER SIMULATION; CONFERENCE PAPER; CONTROLLED DRUG RELEASE; DRUG BLOOD LEVEL; DRUG DESIGN; DRUG FORMULATION; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PHARMACOKINETICS; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; ANTIHYPERTENSIVE AGENTS; CALCIUM CHANNEL BLOCKERS; CHEMISTRY, PHARMACEUTICAL; COMPUTER SIMULATION; DELAYED-ACTION PREPARATIONS; DRUG DESIGN; HUMANS; MODELS, CHEMICAL; NITRENDIPINE; TIME FACTORS;

EID: 0032125308     PISSN: 00104825     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0010-4825(98)00020-1     Document Type: Conference Paper

References (7)

1. Kristl A., Vojnovic D., Karba R., Mrhar A., Rubessa F., Zupančič B. Mixture design of theophyline retard formulation. International Journal of Pharmaceutics. 99:1993;33.
2. Goa K.L., Sarkin E.M. Nitrendipine, a review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the treatment of hypertension. Drugs. 33:1987;123.
3. K.D. Raemsch, J. Sommer, Pharmacokinetics and metabolism of nitrendipine, in: Scriabne et al. (Eds.), Nitrendipine, Urban and Schwarzenberg, 1984, p. 409.
4. Remunan C., Mrhar A., Primoźič S., Karba R., Vila-Jato J.L. Sustained release nifedipine formulations: moment, modelling and simulation as pharmacokinetic analysis approach. Drug Development Industrial Pharmacy. 18:1992;187.
5. Matlab Reference Guide, The MathWorks, 1992.
6. R. Karba, A. Mrhar, B. Zupančič, M. Atanasijević-Kunc, A. Belič, The role of simulation tool in histamine pharmacokinetical model development, in: T.I. Oren, L.G. Birta (Eds.), Proceedings of the 1995 summer computer simulation conference, Ottawa, 1995, p. 685.
7. Johnson B.F., Romero L., Mrwaha R. Hemodynamic and metabolic effects of the calcium channel blocking agent nitrendipine. Clinical Pharmacology and Therapeutics. 39:1986;389.